BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2079482)

  • 1. Congenital dyserythropoietic anaemia.
    Prasher N; Prasher BS
    J Assoc Physicians India; 1990 Nov; 38(11):877. PubMed ID: 2079482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment of congenital dyserythropoietic anemia type I with long-term administration of deferoxamine].
    Miyazawa K; Yoshikawa O; Takakuwa Y; Tuda A; Ohtaka M; Lin KY; Iguchi Y; Naruto M; Kondo M; Toyama K
    Rinsho Ketsueki; 1988 Sep; 29(9):1454-9. PubMed ID: 3063858
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission from transfusion-dependence in a patient with congenital dyserythropoietic anemia (CDA) and increased intensity of iron chelation.
    Bergmann AK; Tamary H; Neufeld EJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1167-8. PubMed ID: 19606459
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital dyserythropoietic anaemia.
    Mehta BC; Mehta JB
    J Assoc Physicians India; 1990 Mar; 38(3):253. PubMed ID: 2391325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Congenital dyserythropoietic anemia].
    Kallo J
    Vnitr Lek; 1991 Feb; 37(2):172-7. PubMed ID: 2021078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyserythropoietic syndromes: incidence, diagnosis, therapy].
    Cacciola E
    Recenti Prog Med; 1990 Oct; 81(10):651-4. PubMed ID: 2291009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital dyserythropoietic anemia type III. A case report].
    Holm T; Kildahl-Andersen O; Sjo M
    Tidsskr Nor Laegeforen; 1997 May; 117(13):1898-9. PubMed ID: 9214009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine therapy in a fetus with congenital dyserythropoietic anaemia type I.
    Lin SM; Chen M; Ma ES; Lam YH; Wong KY; Tang MH
    J Obstet Gynaecol; 2014 May; 34(4):352-3. PubMed ID: 24724939
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital dyserythropoietic anaemias: splenectomy as a mode of therapy.
    Choudhry VP; Saraya AK; Kasturi J; Rath PK
    Acta Haematol; 1981; 66(3):195-201. PubMed ID: 6795878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the understanding of the congenital dyserythropoietic anaemias.
    Wickramasinghe SN; Wood WG
    Br J Haematol; 2005 Nov; 131(4):431-46. PubMed ID: 16281933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation.
    Ayas M; al-Jefri A; Baothman A; al-Mahr M; Mustafa MM; Khalil S; Karaoui M; Solh H
    Bone Marrow Transplant; 2002 Apr; 29(8):681-2. PubMed ID: 12180113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anemia caused by congenital dyserythropoiesis: type II (Hempas). Value of splenectomy].
    Sondag D; Weill JP; Oberling F
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2419. PubMed ID: 7111012
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
    Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
    Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anaemia.
    Prasher N; Prasher BS
    J Assoc Physicians India; 1989 Jul; 37(7):467-8. PubMed ID: 2613664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS). (Ultrastructural changes in erythrocytes after splenectomy)].
    Chrobák L; Spacek J
    Vnitr Lek; 1997 Oct; 43(10):635-8. PubMed ID: 9601875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and clinical course of congenital dyserythropoietic anaemia type 1 in a 12-year-old girl.
    Rössler J; Heimpel H; Havers W
    Eur J Pediatr; 2001 Feb; 160(2):139-40. PubMed ID: 11271388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leg ulcers in congenital dyserythropoietic anemia].
    Gschnait F; Duschet P; Krieger O; Baumgartner G; Luger A; Stacher A
    Z Hautkr; 1985 Jan; 60(1-2):199-203. PubMed ID: 3885599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant therapy for severe cardiac failure induced by iron overload secondary to dyserythropoietic anaemia.
    van der Merwe J; Leong JY; Kaye D; Opat S; Bergin PJ; Taylor AJ; Rosenfeldt F
    Heart Lung Circ; 2007 Oct; 16(5):394-7. PubMed ID: 17314073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital dyserythropoietic anaemia, type I: a new case (author's transl)].
    Romero C; Fernández-Fuertes I; César J; Hernández-Jodra M; Woessner S; Navarro JL
    Sangre (Barc); 1980; 25(4):507-14. PubMed ID: 7423342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Type II congenital dyserythropoietic anaemia. Report of two cases (author's transl)].
    Javier G; Domingo A; Sáenz A; Ortega JJ
    Sangre (Barc); 1981; 26(5-A):638-45. PubMed ID: 7323920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.